Luliderm Lotion contains Luliconazole 1% w/v, an imidazole antifungal agent indicated for the topical treatment of superficial fungal infections of the skin, including tinea corporis, tinea cruris, and tinea pedis. Luliconazole exerts its antifungal effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. This lotion formulation allows for effective penetration into the stratum corneum, ensuring targeted action against dermatophytes and yeasts such as Candida species. Luliderm Lotion is typically applied once daily to the affected area and surrounding skin after cleansing and drying, with treatment duration varying according to the infection type but generally ranging from one to two weeks. It is well tolerated, with adverse effects being rare and usually limited to mild local reactions such as burning, itching, or erythema at the application site. Luliderm Lotion should be used with caution in patients with known hypersensitivity to luliconazole or any excipients. It is contraindicated for use on mucous membranes and should not be applied to open wounds. Proper adherence to the prescribed regimen is essential to ensure complete eradication of the fungal infection and to prevent recurrence.